Investor Information
Company Profile
Tactile Systems Technology Inc., headquartered in Minneapolis, Minnesota, is a rapidly growing, privately-held corporation. The company manufactures and sells the Flexitouch system, a patented medical device with a highly defined market. We were honored by the Lymphatic Research Foundation as the 2007 Corporation of the Year, the first such award in the foundation’s history. From its inception in 1995, the company has been funded by individual investors. In October 2007, our first institutional investor, Galen Partners, led a new round of funding. Galen Partners is a private equity firm focused solely on healthcare investments with over $1 billion under management.
Company Snapshot
- Direct sales and billing
- Product specialists serving lymphedema patients across the United States
- Primary focus on lymphedema treatment
- Strong revenue growth
- Published clinical validation
- Approved Medicare coding
- Reimbursement from payers nationwide
- Satisfied patients and therapists
- Proven, scalable business model
- Experienced management team
- Accredited by the Accreditation Commission for Health Care, Inc.
The Flexitouch System
The company received FDA 510(k) clearance to market the Flexitouch system for treatment of lymphedema and chronic wounds. Over 90 percent of Flexitouch users report being either satisfied or extremely satisfied with their system and 95 percent report continuing compliance. As a result, these patients experience a reduction in symptoms and complications including risk of infection, hospitalization and other debilitating and costly consequences.
Prevalence of Lymphedema
An estimated one in four breast cancer survivors will develop lymphedema within the first two years after treatment. Currently the prevalence of lymphedema among cancer survivors is estimated at over 800,000 patients, with an additional 64,000 cases diagnosed each year. Lymphedema is also caused by prostate and gynecologic cancer intervention, infection, chronic venous disease, burns, paralysis and excess weight.
Reimbursement
More than 280 insurance companies and government agencies, including Medicare, provide reimbursement coverage for the Flexitouch system. Our dedicated team of reimbursement specialists works closely with patients, therapists and payers to secure reimbursement for clinically appropriate patients.